BACKGROUND: Congenital heart disease (CHD), the most common birth defect and a leading cause of infant mortality, is ...

BACKGROUND: Bisphenol F (BPF) is a common substitute for bisphenol A and the most prevalent bisphenol compound in diverse ...

Testing for the prothrombin 20210 mutation, also called factor II mutation, may have been offered by your doctor because you or someone in your family, has had (1) a blood clot in one of the deep ...

There is only limited knowledge on the time course of perihemorrhagic edema (PHE) after intracerebral hemorrhage (ICH). We aimed to investigate the chronological PHE course and its relation to ...

The heart transplant allocation system is evolving in response to increasing demand for donor organs, technological advances, and changes in medical decision-making. In this evolving landscape, the ...

Dabigatran etexilate is a prescription medication used to slow and inhibit the formation of blood clots. Dabigatran is known by the trade name Pradaxa in the United States and all other countries in ...

Most physicians in the 1920s were general practitioners with relatively little postgraduate training. Although they measured blood pressure routinely, electrocardiograms and chest X-rays were in the ...

Arrhythmogenic cardiomyopathy (ACM) is a heritable heart muscle disease associated with increased risk of sudden cardiac death. The only treatment proven to reduce this risk is an implantable ...

Fifty years ago, many children born with complex CHD could only, at best, be palliated for the first year(s) of life if at all. In the 1970s and 1980s, several surgical innovative procedures were ...

Emelia J. Benjamin, MD, ScM, FAHA, Chair, Paul Muntner, PhD, MHS, FAHA, Vice Chair, Alvaro Alonso, MD, PhD, FAHA, Marcio S. Bittencourt, MD, PhD, MPH, Clifton W ...

Introduction: Prior studies have shown the association between oral infection, incident stroke and atrial fibrillation (AF) a cause of cardioembolic stroke. However, the impact of preventative oral ...

The first genetic insights into hypertrophic cardiomyopathy (HCM) arose from linkage analyses in families with many affected individuals. The findings were compatible with monogenic inheritance, ...